US pharmaceutical reshoring threatens revenue for China's contract drug makers
ConfirmedSanctions · CN
36
Severity
70%
Confidence
1
Events
KScore
2.3 Caution
1 independent sources
First report: Mar 17, 11:48 AMLatest report: Mar 17, 11:48 AM
Event Timeline (1)
BHigh Credibility
US reshoring drive casts shadow over China’s contract drug makers: analyst

